Consolidated Balance Sheets (As Restated) (Current Period Unaudited) (Parentheticals) - USD ($)		Dec. 31, 2016	Mar. 31, 2016
Cash and cash equivalents		$ 1,621,890	$ 5,345,455	[1]
Allowance for doubtful accounts		437,000	426,000	[2]
Accounts receivable		15,239,948	12,303,128	[1]
Inventories		20,946,720	12,274,104	[1]
Prepaid expenses and other		1,192,275	1,668,004	[1]
Property and Equipment, net		5,168,905	4,577,774	[1]
Other Assets		402,439	317,528	[1]
Intangible assets, net		1,139,922	1,109,112	[1]
Goodwill		4,185,265	275,408	[1]
Accounts payable		9,054,684	7,003,660	[1]
Income tax payable			11,312	[1]
Accrued expenses		6,706,927	6,842,874	[1]
Short-term debt		$ 1,163,577	$ 1,859,300	[1]
Preferred stock, par value (in dollars per share)		$ 1	$ 1	[2]
Preferred stock, authorized (in shares)		50,000	50,000	[2]
Common stock, par value (in dollars per share)		$ 0.25	$ 0.25
Common stock, authorized (in shares)		4,000,000	4,000,000
Common stock, issued (in shares)		2,042,789	2,372,527
Common stock, outstanding (in shares)		2,042,789	2,372,527
Delphax [Member]
Cash and cash equivalents	[3]	$ 95,357	$ 249,528	[2]
Accounts receivable	[3]	2,000,183	1,433,494	[2]
Inventories	[3]	2,014,783	4,642,298	[2]
Prepaid expenses and other	[3]	491,331	1,034,067	[2]
Property and Equipment, net	[3]	33,474	625,684	[2]
Other Assets	[3]	0	26,020	[2]
Intangible assets, net		0	1,109,112	[2],[3]
Goodwill		0	275,408	[2],[3]
Accounts payable	[3]	2,577,816	1,684,802	[2]
Income tax payable	[3]	11,312	11,312	[2]
Accrued expenses		3,562,787	1,926,340
Short-term debt		$ 1,163,577	$ 1,859,300

[1] Derived from audited consolidated financial statements

[2] Derived from audited consolidated financial statements

[3] Amounts related to Delphax as of December 31, 2016 and March 31, 2016, respectively